Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Lymphoid 9Plasma cell 8Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1

Conditions

Neoplasms 1

Interventions

Surveys and Questionnaires 48Blood Specimen Collection 22Interviews as Topic 14Data Collection 11Magnetic Resonance Spectroscopy 6Hematologic Tests 6Specimen Handling 5Restraint, Physical 5Radiotherapy 5Palliative Care 4Observation 4Mental Status and Dementia Tests 4Watchful Waiting 3Registries 3Quality of Life 3Phlebotomy 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Lapatinib 3Immunotherapy 3Immune Checkpoint Inhibitors 3Health Records, Personal 3Focus Groups 3Drug Therapy 3Bevacizumab 3Absorptiometry, Photon 3veliparib 2talazoparib 2rucaparib 2pamiparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lenalidomide × Tumor-Agnostic × Clear all
NCT06251648 2024-02-09

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

University Hospital, Caen

Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡